Contineum Therapeutics (Contineum Therapeutics) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2024)

Competitive Comparison of Contineum Therapeutics's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Contineum Therapeutics's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Contineum Therapeutics's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Contineum Therapeutics's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Contineum Therapeutics's 3-Year Dividend Growth Rate falls into.

Contineum Therapeutics 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Contineum Therapeutics  (NAS:CTNM) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Contineum Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Contineum Therapeutics 3-Year Dividend Growth Rate Related Terms>

Contineum Therapeutics (Contineum Therapeutics) Business Description